Skip to content
Subscriber Only

Zogenix Pain Drug May Have Higher Abuse Risk, FDA Staff Says

Zogenix Inc.’s pure hydrocodone painkiller Zohydro may be abused at a greater rate if approved than combination products on the market, U.S. regulators said.

Food and Drug Administration staff asked outside advisers in a report today to weigh the effectiveness of the extended-release pill against its risk of abuse. The advisers will meet Dec. 7 to decide whether to recommend the medicine’s approval.